{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:03:53Z","timestamp":1775815433783,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N90023C00013"],"award-info":[{"award-number":["75N90023C00013"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09550-5","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:13:41Z","timestamp":1772583221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Continuum of care in hospitalized patients with opioid or stimulant use disorder and infectious complications of drug use\u2014substance use\/infectious disease integrated clinic compared to treatment as usual to prevent infection-related readmission (CHOICE-STAR): a study protocol for an effectiveness-implementation randomized controlled trial"],"prefix":"10.1186","volume":"27","author":[{"given":"Elana S.","family":"Rosenthal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Claude C.","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Traver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Gryczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Nordeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Reece","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian S.","family":"Catalanotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaina R.","family":"Steck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako Wendy","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan E.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habib Omari","family":"Ramadhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Silk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Masur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Kattakuzhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"7","key":"9550_CR1","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1093\/cid\/ciaa008","volume":"71","author":"NL McCarthy","year":"2020","unstructured":"McCarthy NL, Baggs J, See I, Reddy SC, Jernigan JA, Gokhale RH, et al. Bacterial Infections Associated With Substance Use Disorders, Large Cohort of United States Hospitals, 2012\u20132017. Clin Infect Dis. 2020;71(7):e37-44.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"9550_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cid\/ciac543","volume":"76","author":"H Bradley","year":"2023","unstructured":"Bradley H, Hall EW, Asher A, Furukawa NW, Jones CM, Shealey J, et al. Estimated Number of People Who Inject Drugs in the United States. Clin Infect Dis. 2023;76(1):96\u2013102.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"9550_CR3","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/S2214-109X(23)00057-8","volume":"11","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S, et al. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. Lancet Glob Health. 2023;11(5):e659\u201372.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"9550_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.7326\/M18-2124","volume":"170","author":"AJ Schranz","year":"2019","unstructured":"Schranz AJ, Fleischauer A, Chu VH, Wu LT, Rosen DL. Trends in Drug Use-Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017: A Study of Statewide Discharge Data. Ann Intern Med. 2019;170(1):31\u201340.","journal-title":"Ann Intern Med"},{"issue":"17","key":"9550_CR5","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1161\/CIRCULATIONAHA.123.066921","volume":"149","author":"A Anuforo","year":"2024","unstructured":"Anuforo A, Aneni E, Akintoye E, Anikpezie N, Patel SD, Soipe A, et al. Trends in Age, Sex, and Racial Differences in the Incidence of Infective Endocarditis in Florida and New York. Circulation. 2024;149(17):1391\u20133.","journal-title":"Circulation"},{"issue":"12","key":"9550_CR6","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/add.16318","volume":"118","author":"J Friedman","year":"2023","unstructured":"Friedman J, Shover CL. Charting the fourth wave: geographic, temporal, race\/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010\u20132021. Addiction. 2023;118(12):2477\u201385.","journal-title":"Addiction"},{"issue":"1","key":"9550_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-022-00624-6","volume":"19","author":"A Hrycko","year":"2022","unstructured":"Hrycko A, Mateu-Gelabert P, Ciervo C, Linn-Walton R, Eckhardt B. Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage. Harm Reduct J. 2022;19(1):1\u201313.","journal-title":"Harm Reduct J"},{"key":"9550_CR8","doi-asserted-by":"crossref","unstructured":"Brothers TD, Bonn M, Lewer D, Comeau E, Kim I, Webster D, et al. Social and structural determinants of injection drug use-associated bacterial and fungal infections: a qualitative systematic review and thematic synthesis. Addiction. 2023.","DOI":"10.1101\/2022.10.02.22280620"},{"issue":"6","key":"9550_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","volume":"70","author":"CL Mattson","year":"2021","unstructured":"Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"21","key":"9550_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209298","volume":"160","author":"NM Robertson","year":"2024","unstructured":"Robertson NM, Mangino AA, South AM, Fanucchi LC. Medications for opioid use disorder associated with reduced readmissions for patients with severe injection-related infections: a matched cohort study. J Subst Use Addict Treat. 2024;160(21):209298.","journal-title":"J Subst Use Addict Treat"},{"key":"9550_CR11","doi-asserted-by":"publisher","unstructured":"Thakrar AP, Lowenstein M, Greysen SR, Delgado MK. Trends in Before Medically Advised Discharges for Patients With Opioid Use Disorder, 2016-2020. JAMA. 2023 Dec 4. Available from: https:\/\/doi.org\/10.1001\/jama.2023.21288. Cited 5 Dec 2023.","DOI":"10.1001\/jama.2023.21288"},{"issue":"12","key":"9550_CR12","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1097\/QAD.0000000000003629","volume":"37","author":"ES Rosenthal","year":"2023","unstructured":"Rosenthal ES, Brokus C, Sun J, Carpenter JE, Catalanotti J, Eaton EF, et al. Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections. AIDS. 2023;37(12):1799.","journal-title":"AIDS"},{"key":"9550_CR13","doi-asserted-by":"crossref","unstructured":"Wildenthal JA, Atkinson A, Lewis S, Sayood S, Nolan NS, Cabrera NL, et al. Outcomes of Partial Oral Antibiotic Treatment for Complicated S. aureus Bacteremia in People Who Inject Drugs. Clin Infect Dis. 2022:ciac714.","DOI":"10.1093\/cid\/ciac714"},{"issue":"8","key":"9550_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.12974","volume":"3","author":"C Tan","year":"2020","unstructured":"Tan C, Shojaei E, Wiener J, Shah M, Koivu S, Silverman M. Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective Endocarditis. JAMA Netw Open. 2020;3(8):e2012974.","journal-title":"JAMA Netw Open"},{"key":"9550_CR15","doi-asserted-by":"crossref","unstructured":"Serota DP, Rosenbloom L, Hervera B, Seo G, Feaster DJ, Metsch LR, et al. Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use\u2013Associated Infections: A Prospective Cohort Study With Historical Control. Open Forum Infect Dis. 2023;10(1):ofac688.","DOI":"10.1093\/ofid\/ofac688"},{"key":"9550_CR16","doi-asserted-by":"crossref","unstructured":"Lewis S, Liang SY, Schwarz ES, Liss DB, Winograd RP, Nolan NS, et al. Patients With Serious Injection Drug Use\u2013Related Infections who Experience Patient-Directed Discharges on Oral Antibiotics Have High Rates of Antibiotic Adherence but Require Multidisciplinary Outpatient Support for Retention in Care. Open Forum Infect Dis. 2022;9(2):ofab633.","DOI":"10.1093\/ofid\/ofab633"},{"key":"9550_CR17","doi-asserted-by":"publisher","unstructured":"Traver EC, Omari H, Stevens J, Derenoncourt M, Flores HE, Vaish IK, et al. P-1418. Risk for Early and Late Readmission for Serious Injection-Related Infections: the CHOICE+ Cohort. In: Open Forum Infectious Diseases. Los Angeles; 2024:ofae631.1593. Available from: https:\/\/doi.org\/10.1093\/ofid\/ofae631.1593. Cited 19 May 2025.","DOI":"10.1093\/ofid\/ofae631.1593"},{"key":"9550_CR18","doi-asserted-by":"crossref","unstructured":"Rosenthal ES, Kattakuzhy S, Omari H, Stevens J, Derenoncourt M, Vaish IK, et al. P-1417. High Rates of Patient Directed Discharge Associated with Incomplete Treatment and Rehospitalization in People Hospitalized with Serious Injection Related Infections: The CHOICE+ Cohort. Open Forum Infect Dis. 2025;12(Supplement_1):ofae631.1592.","DOI":"10.1093\/ofid\/ofae631.1592"},{"issue":"1","key":"9550_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10488-010-0327-7","volume":"38","author":"GA Aarons","year":"2011","unstructured":"Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of evidence-based practice implementation in public service sectors. Adm Policy Ment Health. 2011;38(1):4\u201323.","journal-title":"Adm Policy Ment Health"},{"issue":"2","key":"9550_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"95","key":"9550_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"1","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;1(95):103208.","journal-title":"J Biomed Inform"},{"issue":"212","key":"9550_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107987","volume":"1","author":"TL Rowell-Cunsolo","year":"2020","unstructured":"Rowell-Cunsolo TL, Liu J, Hu G, Larson E. Length of hospitalization and hospital readmissions among patients with substance use disorders in New York City, NY USA. Drug Alcohol Depend. 2020;1(212):107987.","journal-title":"Drug Alcohol Depend"},{"key":"9550_CR23","unstructured":"SAS Institute Inc. SAS software [computer program]. Version 9.4. Cary, NC: SAS Institute Inc; 2020."},{"key":"9550_CR24","unstructured":"CHERISH. Instruments & Measures. Available from: https:\/\/cherishresearch.org\/tools-and-resources\/instruments-and-measures\/.\u00a0Cited 23 June 2025."},{"issue":"1","key":"9550_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","volume":"168","author":"AT McLellan","year":"1980","unstructured":"McLellan AT, Luborsky L, Woody GE, O\u2019Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168(1):26\u201333.","journal-title":"J Nerv Ment Dis"},{"issue":"2\u20133","key":"9550_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.drugalcdep.2006.09.002","volume":"87","author":"JS Cacciola","year":"2007","unstructured":"Cacciola JS, Alterman AI, McLellan AT, Lin YT, Lynch KG. Initial evidence for the reliability and validity of a \u201cLite\u201d version of the Addiction Severity Index. Drug Alcohol Depend. 2007;87(2\u20133):297\u2013302.","journal-title":"Drug Alcohol Depend"},{"key":"9550_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106651","volume":"113","author":"RK McHugh","year":"2021","unstructured":"McHugh RK, Trinh CD, Griffin ML, Weiss RD. Validation of the craving scale in a large sample of adults with substance use disorders. Addict Behav. 2021;113:106651.","journal-title":"Addict Behav"},{"issue":"7","key":"9550_CR28","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1176\/appi.ajp.160.7.1320","volume":"160","author":"RD Weiss","year":"2003","unstructured":"Weiss RD, Griffin ML, Mazurick C, Berkman B, Gastfriend DR, Frank A, et al. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. Am J Psychiatry. 2003;160(7):1320\u20135.","journal-title":"Am J Psychiatry"},{"key":"9550_CR29","unstructured":"Bohn M, Babor T, Kranzler H. Validity of the Drug Abuse Screening Test (DAST-10) in Inpatient Substance Abusers. In: Proceeding of the 53rd Annual Scientific Meeting The Committee on Problems of Drug Dependence, Inc. National Institute on Drug Abuse; 1991. p. 233."},{"issue":"4","key":"9550_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0306-4603(82)90005-3","volume":"7","author":"HA Skinner","year":"1982","unstructured":"Skinner HA. The drug abuse screening test. Addict Behav. 1982;7(4):363\u201371.","journal-title":"Addict Behav"},{"issue":"177","key":"9550_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drugalcdep.2017.03.022","volume":"1","author":"CL Vilsaint","year":"2017","unstructured":"Vilsaint CL, Kelly JF, Bergman BG, Groshkova T, Best D, White W. Development and validation of a Brief Assessment of Recovery Capital (BARC-10) for alcohol and drug use disorder. Drug Alcohol Depend. 2017;1(177):71\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"9550_CR32","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1989.tb03059.x","volume":"84","author":"TF Heatherton","year":"1989","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791\u20139.","journal-title":"Br J Addict"},{"issue":"5","key":"9550_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0740-5472(97)00132-3","volume":"14","author":"MT French","year":"1997","unstructured":"French MT, Dunlap LJ, Zarkin GA, McGeary KA, Thomas McLellan A. A structured instrument for estimating the economic cost of drug abuse treatment: the drug abuse treatment cost analysis program (DATCAP). J Subst Abuse Treat. 1997;14(5):445\u201355.","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"9550_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/0272989X18776637","volume":"38","author":"B Dewitt","year":"2018","unstructured":"Dewitt B, Feeny D, Fischhoff B, Cella D, Hays RD, Hess R, et al. Estimation of a preference-based summary score for the Patient-Reported Outcomes Measurement Information System: the PROMIS\u00ae-preference (PROPr) scoring system. Med Decis Making. 2018;38(6):683\u201398.","journal-title":"Med Decis Making"},{"issue":"12","key":"9550_CR35","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1007\/s11136-017-1686-2","volume":"26","author":"J Hanmer","year":"2017","unstructured":"Hanmer J, Cella D, Feeny D, Fischhoff B, Hays RD, Hess R, et al. Selection of key health domains from PROMIS\u00ae for a generic preference-based scoring system. Qual Life Res. 2017;26(12):3377\u201385.","journal-title":"Qual Life Res"},{"issue":"221","key":"9550_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108589","volume":"1","author":"C Fong","year":"2021","unstructured":"Fong C, Mateu-Gelabert P, Ciervo C, Eckhardt B, Aponte-Melendez Y, Kapadia S, et al. Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City. Drug Alcohol Depend. 2021;1(221):108589.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"9550_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/intqhc\/mzg043","volume":"15","author":"C McGuiness","year":"2003","unstructured":"McGuiness C, Sibthorpe B. Development and initial validation of a measure of coordination of health care. Int J Qual Health Care. 2003;15(4):309\u201318.","journal-title":"Int J Qual Health Care"},{"issue":"1","key":"9550_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13012-017-0635-3","volume":"12","author":"BJ Weiner","year":"2017","unstructured":"Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, et al. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017;12(1):108.","journal-title":"Implement Sci"},{"key":"9550_CR39","unstructured":"Washington University. Clinical Sustainability Assessment Tool What is clinical sustainability capacity?. 2019. Available from: http:\/\/www.sustaintool.org."},{"issue":"2","key":"9550_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65\u201376.","journal-title":"Adm Policy Ment Health"},{"key":"9550_CR41","volume-title":"Cost-effectiveness in health and medicine","author":"PJ Neumann","year":"2017","unstructured":"Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG. Cost-effectiveness in health and medicine. Second ed. Oxford University Press; 2017.","edition":"Second ed"},{"key":"9550_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199685028.001.0001","volume-title":"Economic evaluation in clinical trials","author":"HA Glick","year":"2014","unstructured":"Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. Oxford University Press; 2014."},{"key":"9550_CR43","volume-title":"Methods for the economic evaluation of health care programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Fourth ed. Oxford university press; 2015.","edition":"Fourth ed"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09550-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09550-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09550-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T09:29:36Z","timestamp":1775813376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09550-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9550"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09550-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was initially approved by the WCG IRB on August 9, 2024. The study is registered in ClinicalTrials.gov NCT06513156 (\n                      \n                      ). The consent form for the trial participants is included in Supplement 1.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Willing to provide a participant model consent form on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"JG\u2014no financial or competing interests to report; unrelated to the present study: part owner of COG Analytics, LLC; MPI on a NIDA-funded study that received in-kind medication from Indivior and Alkermes. All remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"291"}}